Bithionol manufacturers and suppliers

Bithionol suppliers

Properties

Melting point:: 188°C

Boiling point:: 444.7±45.0 °C(Predicted)

Density: 1.61

storage temp.: Keep in dark place,Inert atmosphere,Room temperature

solubility: DMSO: soluble20mg/mL, clear

pka: 4.82, 10.50(at 25℃)

form: powder

color: white to beige

Water Solubility: <0.1 g/100 mL at 23 ºC

Merck: 14,1306

BRN: 2003535

Stability:: Stable. Incompatible with strong oxidizing agents.

Major Application: cleaning products
clinical
cosmetics
food and beverages
forensics and toxicology
personal care
pharmaceutical (small molecule)

InChI: 1S/C12H6Cl4O2S/c13-5-1-7(15)11(17)9(3-5)19-10-4-6(14)2-8(16)12(10)18/h1-4,17-18H

InChIKey: JFIOVJDNOJYLKP-UHFFFAOYSA-N

SMILES: Oc1c(Cl)cc(Cl)cc1Sc2cc(Cl)cc(Cl)c2O

CAS DataBase Reference: 97-18-7(CAS DataBase Reference)

NIST Chemistry Reference: Bis(2-hydroxy-3,5-dichlorophenyl)sulfide(97-18-7)

EPA Substance Registry System: Bithionol (97-18-7)

Safety Information

Symbol(GHS): GHS06

Signal word: Danger

Hazard statements: H300

Precautionary statements: P264-P270-P301+P310-P405-P501

PPE: Eyeshields, Faceshields, Gloves, type P3 (EN 143) respirator cartridges

Hazard Codes: T+,Xn

Risk Statements: 28-20/21/22

Safety Statements: 28-36/37-45-36

RIDADR: UN 2811 6.1/PG 2

WGK Germany: 3

RTECS: SN0525000

TSCA: TSCA listed

HazardClass: 6.1(a)

PackingGroup: II

HS Code: 29309090

Storage Class: 6.1A - Combustible acute toxic Cat. 1 and 2
very toxic hazardous materials

Hazard Classifications: Acute Tox. 2 Oral

Hazardous Substances Data: 97-18-7(Hazardous Substances Data)

Toxicity: LD50 oral in rat: 7mg/kg

Limited Quantities: 100ml (liquid) or 0.5 Kg (solid)

Excepted Quantities: Max Inner Pack (1g or 1ml) and Max Outer Pack (500g or 500ml)

Use

1. Barret-Connor E (1982). Drugs for the treatment of parasitic infection. Med Clin North Am, 66, 245255. 2. Dawes B. Some apparent effects of Bithionol (Actamer) on Fasciola hepatica. Nature. 209, 424 425. 3. Yokogawa M, Muneo I (1965). Paragonimiasis. Adv Parasitol, 3, 99158. 4. Chung HL, Ho LY, Hsu CP, Tsao WJ (1981). Recent progress in studies of Paragonimus and paragonimiasis control in China. Chin Med J, 94, 493494. 5. Kim JS (1970). Treatment of Paragonimus westermani: infections with Bithionol. Am J Trop Med Hyg, 19, 940942. 6. OQuinn SE, Kennedy CB, Isbell KH (1967). Contact photodermatitis due to bithionol and related compounds. J Am Med Ass, 199, 8992.

You can find Bithionol suppliers, manufacturers, and distributors from countries such as China, United States and the United Kingdom here. Browse to the tetrahydrofuran product information displayed by the supplier, as well as the supplier's contact and capability information.